» Articles » PMID: 22252103

Increases of CRF in the Amygdala Are Responsible for Reinstatement of Methamphetamine-seeking Behavior Induced by Footshock

Overview
Publisher Elsevier
Date 2012 Jan 19
PMID 22252103
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests the involvement of corticotropin-releasing factor (CRF) in drug abuse. Here, we evaluated whether CRF modulates the reinstatement of methamphetamine (METH)-seeking behavior induced by stress using a drug-self administration paradigm in rats. Rats were trained to lever-press for intravenous METH (0.02 mg/infusion) accompanied by light and tone (drug-associated cues) and then underwent extinction training (saline substituted for METH without cues). Under the extinction condition, the inhibitory effects of a CRF receptor antagonist on the stress-induced reinstatement of METH-seeking behavior were assessed. Anxiety-like behaviors during METH withdrawal in METH self-administered rats were also evaluated. The non-selective CRF receptor antagonist α-helical CRF(9-41) attenuated METH-seeking behavior induced by footshock stress. CRF levels both in the amygdala and in plasma were significantly increased on day 10 of withdrawal after METH self-administration. However, plasma corticosterone concentrations were unchanged during the withdrawal. In addition, METH-seeking behavior was not affected by an inhibitor of corticosterone synthesis, metyrapone. In the elevated plus maze test, METH self-administered rats showed a decrease in the duration of time spent in the open arms on day 10 of withdrawal. The increased CRF levels in the amygdala may, at least in part, contribute to the footshock-induced reinstatement of METH-seeking behavior and the increase in anxiety-like behavior. The present findings indicate that CRF receptor antagonists would be useful as a therapeutic agent for METH-dependence.

Citing Articles

Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations.

Mantsch J Addict Neurosci. 2022; 4.

PMID: 36531188 PMC: 9757758. DOI: 10.1016/j.addicn.2022.100038.


A mechanistic overview of approaches for the treatment of psychostimulant dependence.

Jensen K, Jensen S, Madsen K Front Pharmacol. 2022; 13:854176.

PMID: 36160447 PMC: 9493975. DOI: 10.3389/fphar.2022.854176.


Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking.

Martin E, Doncheck E, Reichel C, McRae-Clark A Neurobiol Stress. 2021; 15:100364.

PMID: 34345636 PMC: 8319013. DOI: 10.1016/j.ynstr.2021.100364.


Sex- and Brain Region-specific Changes in Gene Expression in Male and Female Rats as Consequences of Methamphetamine Self-administration and Abstinence.

Daiwile A, Jayanthi S, Cadet J Neuroscience. 2020; 452:265-279.

PMID: 33242543 PMC: 8175033. DOI: 10.1016/j.neuroscience.2020.11.025.


Exercise-Based Interventions for Internet Addiction: Neurobiological and Neuropsychological Evidence.

Li S, Wu Q, Tang C, Chen Z, Liu L Front Psychol. 2020; 11:1296.

PMID: 32670157 PMC: 7330165. DOI: 10.3389/fpsyg.2020.01296.